Company news

Nuwellis, Inc. (NASDAQ:NUWE) news

Nuwellis, Inc. news releases on 6ix. Latest, Oct 1, 2026: Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care…

Nuwellis, Inc. (NASDAQ:NUWE) news

Press releases & updates

Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences

Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences

Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity

Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs

Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins

Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical

Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin

Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy

Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow® Installations in Wisconsin

Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth

Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies

Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026

Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴)

Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations

Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit

Nuwellis Appoints Mike McCormick as Chief Executive Officer

Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals

Nuwellis Announces Closing of $6.0 Million Registered Public Offering

Nuwellis Announces Pricing of $6 Million Public Offering

Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label

Nuwellis, Inc. Announces First Quarter 2026 Financial Results

Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026

Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting

Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology

Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat

Nuwellis Announces Aquadex Software Update

Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum

Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services

Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory

Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone

Nuwellis Completes Acquisition of Rendiatech

Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results

Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors

Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

Nuwellis Appoints Carisa Schultz as Chief Financial Officer

Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market

Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy

Nuwellis Announces Changes to Board of Directors

Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings

Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S.

Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum

Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology

Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025

Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®